New patent expiration for ROCHE drug TAMIFLU

Annual Drug Patent Expirations for TAMIFLU
Annual Drug Patent Expirations for TAMIFLU

Tamiflu is a drug marketed by Roche
and is included in two NDAs. It is available from six suppliers. There are two patents protecting this drug and three Paragraph IV challenges.

The generic ingredient in TAMIFLU is oseltamivir phosphate. Six suppliers are listed for this compound. Additional details are available on the oseltamivir phosphate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

Capsule dosed drug patent expirations by year

This chart shows the patent expirations for capsule dosed drugs over the next decade.

The term of drug patents varies. The basic term for a patent is 20 years from the date of patent filing, which generally occurs several years before a drug is approved.
This means that drugs may have 6-12 years of patent-protected sales after launch. There are conditions under which drug patents can be extended, for example to
compensate for time spent waiting for Food and Drug Agency (FDA) review, or for responding to an FDA request for pediatric testing.

Drug patent expirations can also be used as a bellwether for the pharmaceutical industry — a
rise, or fall, in the number of anticipated patent expirations can predict outcomes for branded pharmceutical companies,
generic producers, and for healthcare payers.

The long-range forecast presented here can help model pharmaceutical industry trends for capsule dosed drugs over the coming decade.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

Which pharmaceutical companies have the most drug patents in United Kingdom?

This chart shows the pharmaceutical companies with the most patents in United Kingdom.

Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.

For a global perspective, see the Drug companies with the greatest global patent coverage.

The companies with the greatest patent coverage in United Kingdom are:

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

New patent for Purdue Pharma drug TARGINIQ

Annual Drug Patent Expirations for TARGINIQ
Annual Drug Patent Expirations for TARGINIQ

Targiniq is a drug marketed by Purdue Pharma Lp
and is included in one NDA. There are twenty patents protecting this drug.

This drug has two hundred and fifty-one patent family members in forty-five countries.

The generic ingredient in TARGINIQ is naloxone hydrochloride; oxycodone hydrochloride. Additional details are available on the naloxone hydrochloride; oxycodone hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

Which pharmaceutical drugs have the most drug patents in Slovenia?

This chart shows the drugs with the most patents in Slovenia.

Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.

The companies with the greatest patent coverage in Slovenia are:

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

Which pharmaceutical drugs have the most drug patents in Slovenia?

This chart shows the drugs with the most patents in Slovenia.

Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.

The companies with the greatest patent coverage in Slovenia are:

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

Which pharmaceutical companies have the most gum dosed drugs?

This chart shows the pharmaceutical companies with the most gum dosed drugs.

For a different perspective, see the most popular dosage types.

The companies with the most gum dosed drugs are:

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com